Kelonia Therapeutics Launches with $50 Million Series A Financing to Pioneer Precision Specific Genetic Medicines
BOSTON--(Business WIRE)--Kelonia Therapeutics, a biotech firm revolutionizing in vivo gene shipping, launched currently with a $50 million Collection A funding to usher in a new...